Question 1 of 6 Fundamentals Concept
What is the role of a regulatory submission dossier?
Short answer
A regulatory dossier organizes the quality, nonclinical, clinical and administrative evidence needed for an authority to evaluate a medicine. Its content must match the product, jurisdiction and requested regulatory action.
Why
The Common Technical Document harmonizes the scientific structure of an application across ICH regions: Module 1 is region-specific, Module 2 contains summaries, Module 3 quality, Module 4 nonclinical reports and Module 5 clinical reports. For example, manufacturing control data belong largely in Module 3 while the clinical study reports supporting efficacy are in Module 5. Regional forms, labeling and fees remain different.
Modern applications commonly use eCTD technical standards, but the currently accepted message version and submission rules must be checked with the receiving authority. A complete dossier is not a guarantee of approval: reviewers judge benefit-risk, study design, data integrity and manufacturing evidence. Traceable cross-references and controlled source-document versions reduce avoidable inconsistencies across modules.
Common mistakes
- Calling CTD an internationally identical application in which Module 1 and local filing rules do not matter
The interviewer might ask next
Where would a revised commercial manufacturing process appear in a regulatory dossier?